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Abstract

ECONOMIC IMPACT OF WASTE IN PRESCRIBING, DISPENSING, AND
MEDICATION CONSUMPTION IN THE UNITED STATES
By Sarah A. Almanie, M.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science at Virginia Commonwealth University.
Virginia Commonwealth University, 2015.
Major Director: David A. Holdford, R.Ph., M.S., Ph.D., FAPhA
Professor
Department of Pharmacotherapy and Outcomes Science

OBJECTIVES: This research examines waste associated with the medication use
process which consists of unfilled prescriptions, abandoned prescriptions, or unused
prescription medications. The aim of this study is to quantify the direct medical costs of
medication waste in delivery of care in the United States.
METHODS: A review of published literature and data from the 2012 Medical
Expenditure Panel Survey was used to quantify the number of prescriptions wasted at
different stages of the medication prescribing and use process and the associated costs
were calculated.

RESULTS: In 2012, more than 26 million prescriptions were either unfilled or
abandoned, and more than 225 million resulted in dispensed medications that were not
used. The total cost of this waste was estimated at $30.4 billion.
CONCLUSIONS: Patients who do not fulfill their role in the medication use process
cause significant, avoidable costs to the health care system beyond the health
outcomes not achieved.

Chapter 1

Section1.1: Background

Medicines constitute a major role in the treatment of many diseases; however, not all
medications are consumed by patients. When they are not consumed, they are wasted
and can become a risk to humans and the environment. The risks of drug waste come
from three primary sources: storage, disposal, and nonuse.
Storage
Improperly stored medications in households can cause harm in several ways. One
way is that children may accidentally ingest medications stored in the home and be
poisoned. Another way is by diversion of stored medications for recreational use. This
can occur when young family members experiment with other family members’
controlled substances or when leftover medications are shared with friends or family
members. Finally, stored medicines in the home provide an option for suicide attempts
among individuals.
Studies support the potential harm from stored medications. A survey of emergency
room visits revealed that the number of visits due to non-medical use of prescription
drugs and over the counter medications equaled 1.2 million in 2009, half of which

1

was attributed to opioid analgesics.1 A report from the centers for disease control (CDC)
in 2009 also showed that about 91% of unintentional poisoning deaths in the U.S. were
caused by drug overdoses, commonly, prescription opioids.2
Disposal
Drug disposal is another risk from drug waste. Improper disposal of drugs can make
it into the sewage system and eventually the nation's water supply. A report from the
Associated Press showed that prescription drugs were found in the drinking water for 24
major metropolitan areas across the United States.3 Analysts attributed such water
contamination to the improper disposal of unused medications by humans. Another
study in New York state investigated the presence of pharmaceuticals in two
wastewater treatment plants between the years 2004-2009 and found that processed
wastewater from factories contained high concentrations of opioids and muscle
relaxants.4 Although the risk to humans of drugs in groundwater is not clear, the impact
on marine mammals is more apparent. In 2012, the U.S. geological survey reported a
high prevalence of fish intersex was seen in the Potomac River watershed. Fish intersex
occurs when female fish experience male characteristics and vice versa. Investigators
related such mutations to the presence of hormonal medicines in water.5
Nonuse
Opportunity costs are associated with prescribed medications that are not used by
patients as directed. A report from IMS Health, revealed that around $213 billion in the
United States was wasted in 2012 on prescribed medications. A breakdown of costs
showed that approximately half of these avoidable costs were associated with patients
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who don’t refill their medications, don’t take their medications as directed, or develop
health complications requiring treatment.6
Other research illustrates the costs of medication waste. In a single hospice program
(2005), it was found that the average cost of medications left at death by 100 patients
was between $100 and $200 per patient.7 In 2010, the total amount of prescribed
medications collected in a national prescription take back event was more than 121
tons.8
Defining "Medication Waste"
The literature provides no consistent definition of medication waste, making it difficult
to quantify the problem and compare studies. According to Oxford dictionary, “waste” is
defined as “an act or instance of using or expending something carelessly,
extravagantly, or to no purpose”.9 This definition indicates that anything that is used
carelessly, inefficiently, or ineffectively is waste.
In the literature, medication waste has a variety of definitions. These include:
1. “medicines issued to the patient but not consumed”,10
2. “any drug product, either dispensed by a prescription or purchased over the
counter (OTC), that is never fully consumed”,11
3. “items which have been dispensed but are unused or partly used by patients and
eventually need to be disposed”,12
4. “the consequence of an inappropriate disposal of unused or partially used
ampoules, vials, or syringes of drugs”,13
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5. and “medication that has been spilled, has been rejected for use by the patient,
or otherwise cannot be returned to the pharmacy for reuse”.14
There is a general agreement among these definitions that describes medication
waste as unconsumed or unused medications. However, the definitions differ in the
types of medications being wasted, the intended population, the underlying cause of
wastage, and the way medicines are wasted. Some definitions include over the counter
medications while others are limited to prescription medications. Certain definitions
focus on outpatient populations and others target inpatient medication waste. Some
definitions are limited to waste caused by a patient’s refusal to take the medication or a
left over dose while others are non-specific. Definitions also vary in how medications are
wasted (e.g., improper disposal).
The consequences of medication waste are another source of variation in the
literature. Studies of medication waste differ on the degree to which they examine
impact on health outcomes, health of environmental ecosystems, and financial costs
after being dispensed by pharmacy personnel. In addition, costs incurred prior to
dispensing are not quantified such as preparation costs for each medication not picked
up by a patient. In these cases, waste of labor occurs.
This research provides an operational definition of medication waste that focuses on
medication use in community settings but expands on the definition of waste to include
cost of labor. In this study, medication waste is defined as:
“resource use associated with unfilled, abandoned prescriptions and
prescription medications that are not consumed by patients in the
community”.
4

This definition focuses on medication use that is primarily within the control of the
end consumer (patients) and excludes waste in institutional settings which may occur
for reasons unrelated to patient actions (e.g., spilled chemotherapy, changes in
medication orders resulting in disposal). In the community, patients make most
decisions on where to store medications, how to dispose of them, and whether to take
them or not. In institutional inpatient settings, these choices are typically up to health
care professionals.
The basic elements of medication waste in this study's definition are unfilled
prescriptions, abandoned prescriptions, and unused prescription medications in
outpatient settings. Unfilled prescriptions are those which are prescribed but not
transmitted to the pharmacy for preparation. Unfilled prescriptions waste the time and
resources of prescribers and their support personnel -- time that can be spent on
productive activities, i.e. opportunity cost. Abandoned prescriptions are transmitted or
delivered to the pharmacy but not picked up by the patient. They waste time and
resources of both prescribers and pharmacy personnel. Unused prescription
medications are dispensed but not taken by patients as directed. They waste time and
efforts of prescribers and pharmacy personnel, and they waste medications.
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Section 1.2: Objectives

The main aim of the study is to estimate the direct medical costs in the United States
associated with unfilled prescriptions, abandoned prescriptions, and unused prescription
medications in outpatient settings, excluding any impact on health outcomes. Thus, our
study focuses on wastage in delivery of care but not the impact on patient health
outcomes. The population of interest is ambulatory (out-patient) individuals who receive
their medications in community pharmacy settings in the United States including
pharmacy chains, independent pharmacies, mail order, large discount department and
warehouse stores, grocery stores, outpatient clinics, specialty pharmacies, emergency
department pharmacies. Hospital pharmacies that serve inpatients and long term care
pharmacies were excluded from the study because they represent a separate setting
which is subjected to different rules and regulations.
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Specific aim I:
To estimate the annual direct medical costs of medication waste in delivery of care as a
result of unfilled and abandoned prescriptions.
Specific aim II:
To estimate the annual direct medical costs of medication waste in delivery of care as a
result of unused prescription medications.
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Section 1.3: Rationale

Medication waste is a worldwide problem that is not only associated with financial
impact. It also negatively impacts safety, health and environment. Better understanding
the problem can enable the healthcare system, patients and society to intervene and
minimize the scope of the problem. Our study will contribute to the literature by
examining medication waste from a different perspective. It will study the wasted inputs
of the medication delivery system.
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Section 1.4: Conceptual Framework

Waste associated with the medication use process consists of any written
prescriptions that are (1) not taken to a pharmacy to be filled, (2) taken to be filled but
abandoned at the pharmacy, or (3) dispensed but not consumed as directed. The
economic burden of medication waste is assessed from a societal perspective. When a
societal perspective is used, three main types of costs are typically considered: direct
costs, indirect costs, and intangible costs (summarized in Table 1.1). However, in the
current study we are interested in waste in medication therapy delivery so, only
physician visit costs, dispensing costs, and prescription ingredient costs will be
examined. In other words, this research focuses on input costs associated with delivery
of medication therapy to patients (e.g., waste in time and effort, drugs) and excludes
output costs resulting from the delivery of medications (e.g., resource use associated
with negative health outcomes, lost productivity, , mortality, and morbidity). Figure 1.1
illustrates the conceptual model used in this study.
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Table 1.1 Types of costs associated with societal perspective
Type of cost

Example

Costs related to our
research

Direct medical cost
associated with delivery
of medication therapy

Input costs:
- Outpatient physician’s
visit cost
- Dispensing cost
- Prescription cost*

Direct medical cost
associated with failures
in medication therapy

Output costs**:
- Hospitalization cost
- Emergency department
visit cost
- Outpatient physician’s
visit cost
- Pharmacy cost

Direct non-medical cost

Transportation cost
Disposal cost

Indirect cost

Loss of productivity

Intangible cost

Feeling
Dissatisfaction
Confusion

Other societal cost

Environmental cost

* Prescription cost = dispensing cost + ingredient cost
**Costs related to deterioration in health condition associated with medication waste
The first step in the model occurs when a physician prescribes a medication for use
by a patient. In many cases, the prescription is sent electronically, by phone, or by fax
transmission to be automatically prepared (filled) by the pharmacist for pickup by the
patient. In some cases, the physician gives the patient a hand written prescription to be
dropped off at a pharmacy. Many of these prescriptions are taken to the pharmacy to be
filled but not all of them. Some are never taken by the patient to be filled in a pharmacy
(not filled). Prescriptions that are delivered and filled at the pharmacy can either be
10

dispensed to the patient (picked up) or left at the pharmacy by the patient (abandoned).
A prescription that is abandoned for a defined period of time (usually two weeks) will be
returned to stock. If the patient picks up the prescription from the pharmacy, the
prescribed medication will either be used as directed (used) or not used as directed (not
used). Medications that are not used as directed may be used in way that was not
prescribed or they may not be used at all.
At each step of the prescription writing and filling process, costs are incurred due to
personnel time and effort, supplies, and medication. Any resources used that do not
result in a medication being taken as directed are considered waste. In the base case of
this model, refill orders which don’t require a physician visit are not considered.

Abandoned
Physician
writes a
prescription

Filled

Returned to
stock (RTS)
Used

Picked up

Not filled

Not used

Figure1.1 Model of the medication use process: underlined words represent points
where direct medical costs are incurred.
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Chapter 2

Systematic Literature Review on the Economic Burden of Medication Waste

A systematic literature review on the economic burden of medication prescriptions
waste was completed on October, 2014. The three databases examined were
PubMed/MEDLINE (limited to abstract available, English, and humans), Cumulative
Index to Nursing and Allied Health Literature (CINHAL) and International
Pharmaceutical Abstracts (IPA). The following inclusion and exclusion criteria were
considered in the literature search:
Inclusion criteria
Original studies that:
1. Evaluated costs attributed to medication prescriptions waste (prescriptions not
taken to a pharmacy to be filled, taken to be filled but abandoned at the
pharmacy, or dispensed but not consumed as directed)
2. Quantified the rate or prevalence of unfilled prescriptions, abandoned
prescriptions, and prescriptions dispensed but not consumed as directed
3. Identified reasons or predictors of medication prescription waste
4. Assessed patient, providers, and prescriptions characteristics associated with
medication prescriptions waste
12

Exclusion criteria:
1. Evaluated environmental or safety/health related effects of medication waste
2. Research was not conducted in the United States
3. Evaluated medication waste for inpatient hospital settings, nursing homes and
long term care facilities
4. Studied pediatric populations: this population was excluded because the current
research focuses on patient role in leading to medication waste and children
have a minimum or no control on their actions
The literature review was divided into two parts. The first part reviewed the literature
on unfilled and abandoned prescriptions. The second part reviewed literature on
medications that are picked up but not consumed as directed.
Part 1: Literature review of unfilled and abandoned prescriptions
Search terms used are summarized in Table 2.1. Titles and abstracts of articles were
checked for inclusion and exclusion criteria. The original 1499 articles were reduced to
75 after applying inclusion and exclusion criteria and eliminating duplicates.15-89 Of
these, 11 articles were selected for discussion based on the following criteria:
-

Evaluated cost of unfilled prescriptions, abandoned prescriptions, or
unconsumed prescription medications

-

Most recent studies

-

Not specific to a disease condition

-

More general settings compared to other studies

13

References from the included articles were also reviewed, yielding two relevant
studies.90,91 Literature search and selected articles are summarized in Figure 2.1 and
Table 2.2, respectively.
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Table 2.1 Search terms history for unfilled and abandoned prescriptions

Search term

Eligible articles
PubMed

CINHAL

IPA

Primary non-adherence

6

3

1

Abandoned prescriptions

3

3

2

Unfilled prescriptions

2

2

3

Unclaimed prescriptions

8

1

27

Filling and prescriptions

21

13

21

Cost and abandoned prescriptions

2

1

1

Costs and abandoned prescriptions

1

-

1

Cost and primary non adherence

1

-

-

Costs and primary non-adherence

1

-

-

Cost and abandoned and prescriptions

2

1

1

Costs and abandoned and prescriptions

1

-

1

Total unique eligible articles

75

15

Articles retrieved based on search
terms
n= (1499)
Excluded articles that didn’t met
the inclusion/exclusion criteria
n= (1369)
Eligible articles
n= (130)
Eliminated duplicates
n= (51)
Unique eligible research articles
n= (79)
Excluded reports and review
articles
n= (4)
Unique eligible original research
articles
n= (75)

Articles selected for discussion
n= (11):

Figure 2.1 Flow chart summary of literature search*
*Adapted from: Sattler EL, Lee JS, Perri M,3rd. Medication (re)fill adherence measures
derived from pharmacy claims data in older Americans: a review of the literature. Drugs
Aging. 2013;30:383-399.
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Table 2.2 Summary of included articles of unfilled and abandoned prescriptions
Author

Study design and
sample

Sample size Outcome
measure of
interest to our
model

Period

Setting and
data source

Findings relating
to our research

Shrank
- Cross sectional
et al 2010 cohort study
- All filled
prescriptions within
3 months period

10,349,139
Rate of:
prescriptions 1. Picked-up
prescription
2.Abandoned
prescription with
RTS*
3.Abandoned
prescription with
RTS* then fill

Two weeks

- CVS retail
pharmacy
chain
- Pharmacy
data (CVS)
- PBM data
(Caremark)

- Total abandoned
prescriptions:
3.27%
- Abandoned
prescription with
return to stock:
1.77%
- Abandoned
prescription with
return to stock then
filled: 1.5%

Bergeron - Cross sectional
et al 2013 survey
- Adults (≥ 18 years
old)

344 patients

Rate of primary
non-adherence
before and after
electronic
prescribing

Patients follow
up interviews
occurred
between 6 – 14
days after
physician’s visit

- One
ambulatory
care clinic
- Discharge
summary and
patient’s
phone
interview

- Primary non
adherence rate:
- 6.9% before eprescribing
- 10.6%, 6 months
after e-prescribing
- 2.5%, 12 months
after e-prescribing

Streeter
- Cross sectional
et al 2011 cohort study
- Cancer patients
with new
prescription for an

10,508
patients

Rate of
prescription
abandonment
for newly
initiated oral

90 days

Pharmacy
claims
database

- Prescription

17

abandonment rate =
10%

oral oncolytic agent

oncolytic agent
(reversed
claims)

Gleason
- Cross sectional
et al 2009 study
- Patients with
newly initiated MS
therapy or TNF
blocker agent

10,104
patients

Papke JA - Cross sectional
1999
study
- New prescriptions
that are filled
(prepared), but
unclaimed

18,233
Rate, and cost
prescriptions of unclaimed
prescriptions

Fischer
- Cross sectional
et al 2010 cohort study

195,930
prescriptions

Association
between out of
pocket OOP
payments and
rate of
prescription
abandonment
for newly
initiated MS or
TNF blocker
therapy
(reversed
claims)

Rate of primary
non-adherence

18

90 days

Pharmacy
claims
database

- Prescription

5 days

-Outpatient
hospital
pharmacy
- Hospital
database and
patients’
interview

- Rate of
unclaimed
prescriptions =
4.72%
- Cost/unclaimed
prescription =
$4.99

Open period
(until the end of
data collection
period)

- Outpatient
clinics
- Electronic
prescribing
transactions
- Pharmacy
claim

- Rate of primary

abandonment rate
increased as OOP
payments
increased:
- MS therapy: (5.7
%– 28.5%)
- TNF blocker:
(4.7% - 26.4%)

non-adherence=
28.3%

database
Jackson - Cross sectional
et al 2014 cohort study
- New prescriptions
for chronic
diseases

29,238
Rate of primary
prescriptions medication nonadherence

30 days

- 100 retail
pharmacies
- A large
national
pharmacy
chain
database

- Rate of primary
medication nonadherence =
12.2%

Reabel et
al 2012

12,061
patients

30 days

- Integrated
healthcare
system

- Rate of primary
non-adherence:
- 7% for
antihypertensive
group
- 11% for
antidiabetic group
- 13% for
antihyperlipidemic
group

- Cross sectional
cohort study
- Patients with
newly initiated
prescriptions for an
antihypertensive,
antidiabetic, or
antihyperlipidemic
medication

Shin et al - Cross sectional
2012
cohort study
- Newly initiated
electronic
prescriptions for
acute and chronic
diseases
Kennedy - Cross section
et al 2008 survey
- Medicare
beneficiaries aged

Rate of primary
non-adherence

- Electronic
medical
records
- Pharmacy
information
management
system
569,095
Rate of primary
prescriptions medication nonadherence

14 days

-Pharmacies
at 14 medical
centers
- Electronic
medical
records

- Overall primary
non-adherence
rate = 9.8%

14,464
patients

Undetermined

- Medicare
Current
Beneficiary
Survey

- Overall rate of
unfilled
prescriptions =
4.4%

Rate of unfilled
(abandoned)
prescriptions

19

≥18 years old

(MCBS) 2004
data

Fischer
-Cross sectional
423,616
et al 2011 study
prescription
- All patients having
CVS Caremark’s
PBM drug coverage

Rate of primary
non-adherence

Up to six
months after
prescribing

-Outpatient
settings
- Electronic
prescribing
database
- pharmacy
benefit
management
database

- Rate of primary
non-adherence =
24%

Ding et al -Cross sectional
2013
study

Determine
the validity of
self-reported
primary nonadherence
(new and refill
prescriptions)

30 days

- Emergency
department at
three
hospitals
- Medicaid
pharmacy
claims
database
- Emergency
department
information
system
- Patients’
interview

- Rate of primary
non-adherence =
26%
- Patients’ reported
data had high
sensitivity;
however, low
specificity:
- Sensitivity: report
filling a prescription
for prescriptions
with pharmacy
claims
- Specificity: report
not filling a
prescription for
prescriptions
without pharmacy
claims

- Patients aged ≥
18 years old
discharged from
emergency
department with
Medicaid coverage

1026 patient

20

Thomas
- Cross sectional
et al 2006 survey
- Adults ≥18 years

3,926
patients

Primary nonadherence
(new and refill
prescriptions)

* RTS = Returned to stock

21

Undetermined

- Medical
care centers
in rural areas
of 8
southeastern
states

- 21.6% delay or
not fill a
prescription in one
year

Summary of literature
Before discussing the literature, a point must be clarified about terminology. When
looking at the literature, the terms prescription abandonment and primary nonadherence overlap in studies that analyzed electronic prescriptions. With e-prescribing,
it is difficult to differentiate between prescription abandonment and primary nonadherence because primary non-adherence will result eventually in prescription
abandonment. However, prescription abandonment and primary non-adherence are two
different terms. Primary non-adherence is related to newly initiated prescriptions, and
prescription abandonment includes both new and old prescriptions. For electronic
prescribing, however, the two terms end up being the same thing.
Filled prescriptions
Percentage of Abandoned Prescriptions
A study by Shrank et al (2010) evaluated the rate and predictors of abandoned
prescriptions at a large national pharmacy chain (CVS) and a large national pharmacy
benefit manager (Caremark).15 The study outcome measures which are important for
modeling medication waste are the rate at which prescriptions are filled, rate of
abandoning a prescription with return to stock, and rate of abandoning a prescription
with return to stock then purchasing it later. Authors estimated that the rate of
prescription abandonment with return to stock was 3.27% with 1.5% of abandoned
prescriptions re-purchased at a later date.
The study estimated an approximate cost of $5 per each abandoned prescription
and concluded that the total annual cost of abandoned prescriptions at U.S. pharmacies
22

was more than $500 million. This total only reflected the cost of dispensing and did not
consider other incurred costs such as the cost of a physician’s visit or resource use
associated with negative health outcomes. In addition, the reported abandonment rate
only refers to retail pharmacies and may differ from rates at other outpatient
pharmacies. A study by Bergeron et al (2013) investigated the rate of abandoning new
prescriptions after implementation of electronic prescribing in one ambulatory care
clinic.16 Three patient cohorts were studied: 6 months before e-prescribing, 6 months
after e-prescribing, and 12-18 months after e-prescribing. The prescription
abandonment rate was 6.9% before e-prescribing; increasing to 10.6% after 6 months
of e-prescribing, and stabilizing at 2.5% after 12-18 months. The final rate of 2.5% was
comparable to 3.27% rate obtained by Shrank et al, but was limited to abandonment of
newly initiated prescriptions.
Two other studies investigated the rate of prescription abandonment for newly
initiated prescriptions. Streeter et al (2011) utilized data from a nationally representative
pharmacy database to look at the effect of copayments on abandoning of newly initiated
prescriptions for eight common oncolytic agents.17 An abandoned prescription was
defined as a prescription that is submitted to the pharmacy and has a reversed claim
with no follow up claim. It was found that copayments were significantly associated with
the prescription abandonment estimate of 10%. This rate was higher than other studies
possibly due to the cost of the drugs and the study population.
Gleason et al (2009) examined the rate of abandoned prescriptions among newly
initiated prescriptions for two sets of specialty drugs: TNF blocker therapy and MS
therapy.18 Data for the study came from a database from eight commercial health plans.
23

A trend analysis of the association between copayment and prescription abandonment
rate found that prescription abandonment rate increased with copayments resulting in
an abandonment rate of 4.7% to 26.4% for TNF blocker therapy and 5.7% to 28.5% for
MS therapy.
In summary, the rate of abandonment of prescriptions in community settings ranged
from 3.27% to 10% for most drugs. Abandonment of specialty medicines was much
higher due to special circumstances associated with these drugs such as large copayments.
Among the encountered studies in the literature review, only one attempted to
estimate the cost of abandoned prescriptions. A single hospital outpatient pharmacy in
Texas (1999) estimated its annual cost of abandoned prescriptions at more than
$60,000 although this finding may not be externally valid to other settings.18
Unfilled prescriptions
There are two types of unfilled prescriptions. Unfilled prescriptions for newly initiated
medications are called primary non adherence. Unfilled prescriptions for refills fall into
the category of secondary non-adherence which is defined as filling a prescription but
not taking it as prescribed.
Primary non-adherence
Four studies examined primary non-adherence in outpatient settings. Three
examined primary non-adherence in prescription claims data and the fourth used a
pharmacy database, allowing it to account for cash prescriptions.20
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Fischer et al (2010) found that the rate of primary non-adherence in outpatient clinics
with different specialties was 28.3%. Primary non-adherence was defined as rate at
which patient did not fill new prescriptions.21 Multivariate analysis showed that
prescriptions of chronic diseases including antihypertensives, antidiabetics, and
antihyperlipidemics were less likely to be filled compared to antimicrobial agents. This
may suggest that patients are concerned with quick relief of symptoms rather than long
term effects. In addition to primary non-adherence, the study estimated the rate of
prescription non-fulfillment among all issued prescriptions to be 22.5%.
Jackson et al (2014) estimated that primary non-adherence in prescription
medications of chronic conditions across 100 pharmacies was 12.2%. 20 This estimate
used pharmacy dispensing data which accounted for cash and non-cash claims but only
examined prescriptions for chronic diseases. Primary non-adherence was defined as a
new electronic prescription for a patient aged 18 years and older that is not obtained
within 30 days.
Raebel et al (2012) looked at primary non-adherence in an integrated healthcare
system among three classes of medications: antidiabetic, antihypertensive,
antihyperlipidemic and a fourth class of multiple medications use. 22 Primary nonadherence was defined as not picking up a new prescription medication within 30 days
of order. The rate of primary non-adherence was significantly different between the
three therapeutic groups: 7% for antihypertensives, 11% for antidiabetics, and 13% for
antihyperlipidemics.
A study by Shin et al (2012) also used data from an integrated health system and
found a similar estimate of primary non-adherence rate (9.8%) as Raebel et al.90
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However, it examined primary non-adherence for drug classes used to treat both acute
and chronic conditions.
In summary, definitions of primary non-adherence only varied slightly in the
literature, and studies found that the rate of primary non-adherence varied between 7%
and 28%. Lower percentages were reported in integrated health systems, where there
is more focus to provide better services to patients. Higher percentages were reported
from data drawn from populations which were not nationally representative. The
estimate of primary non-adherence rate by Jackson et al (12.2%) was based on 100
retail pharmacies and considered the best estimate for the base case of the model.
Unfilled prescriptions
Three studies looked at unfilled prescriptions for both new and old prescriptions. The
first study conducted by Kennedy et al (2008) addressed unfilled prescriptions among
Medicare beneficiaries in community settings.23 In the 2004 Medicare Current
Beneficiary Survey (MCBS) Access to Care Survey, 4.6% of participants answered yes
to the question “During the current year, were there any medicines prescribed for you
that you did not get?” It was estimated that 4.4% (1.6 million) of all Medicare
beneficiaries in the United States do not fill their prescriptions.
Fischer et al (2011) examined the rate of unfilled prescriptions by linking data from a
national electronic prescribing system with claims data from a large national pharmacy
benefit manager database.91 Primary non-adherence was estimated as 24%, but
including refill orders decreased the percentage of unfilled prescriptions to 14.5%.
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The third study assessed self-reported prescription filling after an emergency
department visit among Medicaid enrollees, comparing it to the pharmacy claims data
as the gold standard.24 According to patients, 90% of the prescriptions were filled (i.e.
obtained by patients), but pharmacy claims data indicated that only 74% of the
prescribed medications were filled. This indicates that self-report is not an accurate
measure of prescription fulfillment.
Unfilled prescriptions
One study of patients not filling of handwritten prescriptions was conducted by
Thomas et al (2006).25 A telephone survey assessed primary non-adherence in a rural
population to examine the effect of patient satisfaction with care and the quality of
patient-physician relationship on patients’ delay or failure to fill a prescription. The
overall estimated rate of primary non-adherence based on patients’ reports on unfilled
prescriptions was 21.6% among study participants. This estimate may not be nationally
representative because it was limited to rural areas where there are fewer pharmacies,
difficulties in transportation, people with lower education levels and lower incomes.
Part 2: Literature review on unused prescription medications
The published literature on unused prescriptions covers a broad range of topics
including quantifying the amount of unused prescription medications, storage and
disposal practices at households, and possible consequences of unused prescription
medications (water pollution, health impact, cost to healthcare system, non-medical use,
medication sharing, and diversion). This literature review focused on quantifying unused
prescription household medications and those returned to pharmacies. Studies
associated with unused prescription medications in institutional settings like hospital in27

patient and nursing homes care were not considered. Search terms used are
summarized in Table 2.3 and the literature search is summarized in Figure 2.2. Titles
and abstracts of articles were checked for inclusion and exclusion criteria. The overall
search revealed 474 articles. References from the included articles were also reviewed
for additional relevant articles. After applying inclusion and exclusion criteria and
eliminating duplicates, 13 unique eligible articles were found.92-104 Of these, 6 articles
were selected for discussion (Table 2.4), because they were the most recent, were
more generalizable to national settings, and addressed costs as well as quantifying the
amount of unused prescription medications.
Table 2.3. Search terms history for unused prescription medications
Search term

Eligible articles

Total

PubMed IPA CINHAL
Unused prescription medications 1

6

1

Unused medications

2

8

4

Wasted medications

1

1

-

Unique eligible articles

13

28

Articles retrieved based on search
terms
Excluded reports and articles
that:

n= (474)

-did not meet the
inclusion/exclusion criteria
Eligible original research articles

-were not available

n= (24)

n= (450)
Eliminated duplicates
n= (11)

Unique eligible original research
articles
n= (13)

Articles selected for discussion
n= (6)
Figure 2.2 Flow chart summary of literature search

The literature revealed limited research about unused prescription medications in
outpatient settings. The articles can be divided in to two parts: unused prescription
medications in households and unused prescription medications returned to a pharmacy
or medication take back event.
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Table 2.4 Summary of included articles of unused prescription medications
Author

Study design and
sample

Sample
size

Wieczorkiewicz
et al
2013

- Phone survey
- Adults ≥ 18 years
old

Lewis et al
2014

- Survey (face to
face interviews)
- US veterans

Bates et al
2011

- phone and mail
275
survey
participant
- Adult patients who
underwent
urological surgery

Morgan TM

- Cross sectional

Setting and data
source

Findings relating to
our research

445 surveys To determine
households’’ use,
store, and dispose
of medications

- Patients were
phone interviewed

- Average number of
prescription
medications was 4.4
- 30% of respondents
do not use their
prescription
medications regularly
- 23% have expired
prescription
medications

191
participants

Investigate use and
disposal of
prescription opioids

- Veterans Affairs
Palo Alto Health
Care System
(VAPAHCS)
- Electronic
medical records
- Patients’
interviews

- 65.4% of patients
store unused
prescription opioids
- Only one third of
patients used all
prescribed opioids or
discarded unused

- Patients’
satisfaction with
pain

- Chart review
- Phone interview
- Patient
administered
questionnaire

- 67% of patients have
leftover medications
- 90.8% of patients
stored leftover
medications

- One retirement

- Total cost of wasted

73

Outcome measure
of interest to our
model

- use and disposal
of narcotics
- Assessed
30

2001

survey
- Elderly residents
age ≥ 65 years old

participant

Perry et al
2014

- Prescription
medications take
back event
- Patients’ survey

Garey et al
2004

- Community
campaign
- Patients returning
prescription and
over the counter
medications

prescription
medications use

community
- Patients home
interview
- Pill sort at
patients’ homes

medications = $2011
- Average annual cost
per person = $30.47
(2.3% of the total
annual costs per
person)

818 surveys - Quantify
medication waste,
cost, and assess
disposal practices

- One local
community
- Event held for 7
days
- Patient’s
administered
survey

- More than 780
thousand wasted
dosing units with a
total cost of more than
$1 million

-

- One community
pharmacy

- 1315 medication
containers were
returned
- 65% of returned
medications were
prescription
medications
- Total cost of returned
medications = $26,222

- Investigate
quantity, cost, and
types of returned
medications
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Unused prescription medications in households
Four studies assessed the non-use of prescription medications among adult
population (aged 18 years and above). Three of the four studies used phone or mail
surveys to collect data, 92,93,94 and the fourth used both patient surveys and a home
visit.95
Wieczorkiewicz et al (2013) investigated unused medications (prescription and nonprescription) in households in Cook County, Illinois.92 A phone survey revealed that
about one third of patients did not use their medications regularly and expired
prescription medications accumulated in 23% of the study participants. The monetary
cost was not quantified.
Lewis et al (2014) investigated unused prescription opioids among a veteran
population.93 Stockpiling of unused opioids was reported by 65% with only 6.3% of
patients disposing of unused opioids. Stockpiling opioids was associated with
recreational use of these medications in 34% of patients. A similar study by Bates et al
(2011) investigated unused narcotics among discharged patients who underwent
surgery.94 In this study, 67% of patients stockpiled unused narcotics.
Combining home visits with questionnaires, Morgan (2001) found that 52% of
patients in a retirement community wasted 2078 doses of prescription medications (i.e.
medicines kept with no intention to use).95 The total cost of waste was $2011 for the
study group and the average annual cost of wasted prescriptions per participant was
estimated at $30.47. The study looked at both the amount and the cost of wasted
prescription medications, but did not examine wasted physician or pharmacist time.
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A news release in 2006 showed results of a national prescription drug survey
conducted by The National Community Pharmacists Association (NCPA) in
collaboration with Pharmacists for the Protection of Patient Care (P3C) group; the
survey revealed that 49% of patients forgot to take at least some of their prescribed
medications and 24% took less than the prescribed doses.96
Unused prescription medications returned to a pharmacy or a medication take
back event
Several studies examined medications collected in take back events.97,98,99,100 These
studies quantified the amount of unused or expired medications collected, estimated
their associated cost, and surveyed patients about reasons behind non-use. Perry et al
(2014) described 7 prescription medication take back events that were held in a local
community in Ohio.101 This study was the largest of its kind and included all dosage
forms when estimating cost. 800,000 dosing units were collected over 7 days with an
estimated average wholesale cost of more than $1 million.
A study of dropped-off unused medications by Garey et al (2004) in Houston, Texas
found that the majority (65%) of unused medications were prescription medications. 102
The estimated cost of all unused medications returned to the pharmacy was more than
$26,000.
A newly published study (2014) investigated unused medications at households in a
local community.103 In phase 1 of the study, a web survey was conducted; the results
showed that the ratio of unused to used medications was 2:3 with an estimated cost of
unused medications at more than $23,000. In the second phase, a paper based survey
among patients who returned unused medications to community pharmacies was
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conducted. A total of 776 unused medications where returned for disposal at an
estimated cost of more than $59,000. The total cost of unused medications among
adults was extrapolated to be $117.5 billion on the national level.
Overview of the literature
Studies of unfilled, abandoned prescriptions, and unused prescription medications
can allow a model of medication waste to be developed. Only some of the data in the
literature is nationally representative but assumptions and sensitivity analyses can be
used to deal with sources of variability in the data. Using estimates of waste in the
literature, costs can be assigned to estimate the total direct costs associated with
wastage in delivery of care attributed to medication waste.
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Chapter 3

Methods

Study design
A cost of illness model was developed using data from the literature, and a
retrospective cross sectional study of the Medical Expenditure Panel Survey (MEPS)
2012 was conducted. The MEPS is a nationally representative database of the civilian,
noninstitutionalized population of the United States. In the model, direct medical costs of
medication waste (exclusive of impact on health outcomes) were investigated. Indirect
and intangible costs are not considered. Direct medical costs of unfilled, abandoned
prescriptions, and unused prescription medications were estimated over a one year
period using a bottom up approach. All cost estimates were converted to 2014 values
by applying yearly healthcare inflation rates. Prevalence estimates of unfilled,
abandoned prescriptions, and unused prescription medications for U.S. population were
considered in the current study.
Economic model:
Direct medical costs associated with wastage in delivery of care due to medication
waste are illustrated in Figure1.1 (repeated here for convenience of the reader).
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Abandoned
Physician writes
a prescription

Filled
(prepared)

Used
Picked up

Unfilled (not
prepared)

Not used

Figure1.1 Model of the medication use process: underlined words represent points
where direct medical costs are incurred.

Points at which prescription medication waste is identified are:
1. Not filling a prescription (Cost of physician time writing a prescription)
2. Abandoning a prescription (Cost of physician time writing a prescription and a
pharmacist's time preparing the prescription)
3. Picking up a prescription, but not using the prescribed medications (Cost of
physician time writing a prescription, a pharmacist's time preparing the
prescription, and the cost of the medications dispensed but not used as directed)
Model assumptions
The model was built on the following assumptions:
1. 100% of prescriptions transmitted electronically or via fax or phone were by
pharmacists without any action from the patient.
2. For handwritten prescriptions, only those hand-delivered to the pharmacy were
filled by the pharmacist
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3. The rate of unfilled prescriptions was the same as rate of abandoned
prescriptions based on the fact that abandoning a prescription and not delivering
a handwritten prescription to the pharmacy are two separate consequences of
patient’s intention to not fill (obtain) the prescription. The difference between the
two is the nature of the transmittal process of the prescription (i.e. electronic, fax,
phone or hand-delivery)
4. A prescription was considered abandoned after two weeks of delivery to the
pharmacy.
5. Every abandoned prescription was returned to stock
6. Prescriptions with automatic refills were excluded from the model
7. Unused prescription medications were a result of patients’ non-adherence to
drug therapy (i.e. patients do not consume the entire quantity prescribed, leading
to unused leftover medications).
8. A one year period was the time frame of the study
9. The rate of unfilled, abandoned, and unused prescriptions was considered
constant throughout the study period.
Data sources
Prescription data
The total number of prescriptions written in outpatient settings for the year 2012 was
obtained using steps 1 and 2 below:
1. The total number of office based visits, outpatient visits, and emergency room
visits involving written prescriptions was drawn using the variable (MEDPRESC)
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in the three MEPS data files: Office-Based Medical Provider Visits, Outpatient
Visits, and Emergency Room Visits files
2. The total number of prescriptions written in outpatient settings was obtained by
multiplying the total number of all visits involving written prescriptions (in step 1)
by the average number of prescriptions per visit. The National Ambulatory
Medical Care Survey (NAMCS) and The National Hospital Ambulatory Medical
Care Survey (NHAMCS) were used to calculate the average number of
prescriptions written per office based visit, hospital outpatient visit, and
emergency room visit.104,105,106
In 2012, the total number of office based visits, hospital outpatient visits, and
emergency room visits that involved written prescriptions reported in MEPS was
277,226,561 visits. According to NAMCS and NHAMCS, the average number of drug
mentions in one visit varied between 3.4 for office-based visits (2010)104, 3.6 for hospital
outpatient visits (2011) and 2.6 for emergency room visits (2011).105,106 In our base case
model, we assumed the average number of prescriptions written in a single visit at a
conservative total of three. This was done to take into account the fact that some office
based visits include prescriptions for medications that are not self- administered by
patients such as immunizations and other injectables. When the average number of 3
was multiplied by the total number of outpatient visits involving written prescriptions for
the year 2012 (277,226,561), we ended up with a total of 831,679,683 prescriptions per
year. This number was multiplied by the assumed rates of unfilled prescriptions,
abandoned prescriptions, and prescriptions dispensed but not used to get their
respective totals.
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Prevalence estimates
The rate of abandoned prescriptions use in the model was based on the Shrank et al
study (2010) which investigated the rate of prescription abandonment in a large chain
community pharmacy.15 This study was chosen because it examined abandonment of
new and refill prescriptions as well as prescriptions delivered electronically or by hand. It
also used data from a large national pharmacy chain and a large national pharmacy
benefit manager, providing a rate of abandoned prescriptions that should be nationally
representative.
The average rate of prescription medications dispensed but not used as directed
was obtained from Claxton et al (2001)107.This paper was a systematic review which
assessed adherence using electronic monitoring devices. Patients’ adherence was
assessed by looking at whether the appropriate number of doses were taken during
each day or not. The study reported an average rate of adherence of four dose
regimens across a variety of therapeutic classes. Although the review was in 2001, it
was the only encountered study that provided an average rate of unused acute and
chronic medications. The average rate of non-adherence was 29%.
Cost data
Costs of office-based physicians’ visits and other outpatient visits came from
Medicare reimbursement costs for physicians’ fees obtained by using Current
Procedural Terminology (CPT) codes. CPT codes were used to identify physicians’
visits involving an order for a prescription, however, no specific CPT codes were
available for such visits. So, CPT codes used were: 99203 (a physician visit for a
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condition of low to moderate patient severity level and a medical decision of low
complexity for new patients) and 99213 (a physician visit of low to moderate patient
severity level and a medical decision of low complexity for established patients).108 CPT
codes for non-facility based visits were used because most of prescriptions are
generated during office based visits. Average reimbursement of the two codes was
used in the model.
Average dispensing cost was based on a national study which estimated the national
average cost of dispensing per prescription incurred by community retail pharmacies. 109
Cost of dispensing incorporated direct costs, salary expenses, and overhead
costs.109,110
The average prescription cost was obtained from MEPS using the variable
(RXXP12X) from the prescribed medicines file (2012), which represents the mean total
payments (from 12 sources of payments) per each purchased prescription.
Cost calculation
Overall cost of medication waste
A prevalence based method was used to estimate the economic burden of
medication waste. In this method, the prevalence of wasted prescriptions (either
unfilled, abandoned, or unused prescription) during a specific time period (one year)
was measured and assigned a cost using a bottom up approach. In this approach, the
mean cost per unit is calculated and multiplied by the total number of units. Total costs
for unfilled, abandoned, and unused prescription were summed together to obtain the
overall cost.

40

Specific objective 1:
To estimate the annual direct medical costs of medication waste in delivery of care with
regard to unfilled and abandoned prescriptions. The variables considered for estimating
the direct medical costs per an unfilled and abandoned prescription are listed in Table
3.1.
Table 3.1 Cost variables of unfilled and abandoned prescriptions
Cost variable

Costs associated
with unfilled
prescriptions

Costs associated with
abandoned
prescriptions

Mean cost of office based
physicians' visits and other
outpatient visits^

*

*

Mean dispensing cost

*

^Mean

cost of office based physician’s visit and other outpatient visits is computed
based on Medicare reimbursement of physicians’ fees. An average of the average cost
of both new and established patients’ visits is calculated and used. Reimbursement for
other components of physicians’ visits like diagnostic procedures, laboratory services
and prescribed medications are not considered as they don’t fit to the cost of unfilled
and abandoned prescriptions.

Specific objective2:
To estimate the annual direct medical costs of medication waste in delivery of care with
regard to unused prescription medications. The variables considered in estimating the
direct medical costs per an unused prescription are:
-

Mean cost of office based physician’s visit and other outpatient visits

-

Mean prescription cost
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Data analysis
Data were analyzed by decision analysis performed using the TreeAge software, Inc.
v14 for Healthcare. A decision tree was built (see Figure 3.1) mapping out the possible
outcomes of writing a prescription by a physician and assigning probabilities that
unfilled, abandoned, and unused prescription medications will occur as well as its
average cost (in dollars). A folding back technique was used to estimate the expected
value (weighted average cost) per wasted prescription (either unfilled, abandoned, or
unused prescription). This technique works by multiplying the probability that each
outcome will occur by its cost and it starts from the right side of the decision tree (Figure
3.1) and works leftward. Mean cost per unfilled, abandoned, and unused prescription
was also provided at terminal nodes (indicated by triangles at the end of the tree).

Figure 3.1 Decision tree analysis: outcomes that don’t represent medication waste are
assigned zero values; arrow represents point where average weighted cost per
prescription is estimated
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Sensitivity analyses
One way sensitivity analysis and probabilistic sensitivity analysis (PSA) were
performed using the TreeAge software. The aim of these sensitivity analyses was to test
the robustness of the estimated average cost of medication waste. This is due to
uncertainties in the selected parameter estimates such as cost or probabilities of
events. A tornado diagram was made to illustrate the sensitivity of the estimated cost to
the variables used in the model.
In one way sensitivity analysis, the value of one variable is varied in the model while
keeping values of other variables constant. To determine variable ranges used in the
sensitivity analysis, 95% confidence interval limits were used when possible. When no
confidence intervals or standard deviations were reported, the highest and lowest value
estimates reported in the literature were used. When neither of these options were
available, averages for variables were increased and decreased by 20%.
For unused prescription medications, Claxton et al provided a wide range of values
(from 3% to 66%). This was considered too wide for a sensitivity analysis, so a ±20%
range was used.
The rate of abandoned prescriptions also had a wide range in the literature (from
3.27% to 28.3%). The upper range reported by Fischer et al (2010) was not used
because it was not nationally representative. Therefore, the rate of 14.5% reported by
Fischer et al (2011) was used as the upper limit for abandoned prescription rate.
The average prescription cost was reported in MEPS along with the standard error,
so a 95% confidence interval was used as the range for the sensitivity analysis. The
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average cost of physician’s based office visit and other outpatient visits was varied
between zero and the base case value. Average dispensing cost, average number of
prescriptions written per visit and total number of visits involving written prescriptions
were varied over ±20% range.
In PSA, the combined uncertainty of all variables included in the model was tested
using Monte Carlo simulation. Each parameter estimate (for example mean dispensing
cost) was assigned a probability distribution and the software randomly picked a value
for each estimate (for all estimates at the same time) from its distribution to calculate the
mean cost of waste prescription. This process was repeated many times to calculate a
distribution probability for costs of medication waste. In our model, beta distribution was
assigned for outcomes’ probabilities and gamma distribution for cost variables. Beta
distribution limits the output to values between 0 and 1 making it suitable for probability
outcomes. Gamma distribution is recommended for modeling non-negative data such
as cost. When assigning distributions, the mean was set to be equal to the base line
value and the standard deviation was calculated based on the following formula: Upper
limit – lower limit / (2X1.96).111
The process of running the model was repeated with different combinations of
parameter estimates at each time providing the mean of the expected value of the cost
of a wasted prescription. Table 3.2 lists the baseline values and ranges for all variables
included in one way sensitivity analyses and the distributions assigned to each variable
in probabilistic sensitivity analysis.
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Table 3.2 Key variables and ranges used in one way sensitivity analysis
Variable

Baseline

Source

Range

Source

Distribution
assigned
for PSA

Mean office
based
physician’s
visit and
other
outpatient
visits cost*
Mean
dispensing
cost

$30**

CPT
(2014)

($0 – $30)**

***

Gamma

$14

National
cost of
dispensing
study
(2007)

($11 – $17)**

***

Gamma

Mean
prescription
cost

$96

MEPS
(2012)

($90 –
$102)**

MEPS

Gamma

Probability
of
abandoned
prescriptions

0.033

Shrank et
al (2010)

(0.026 0.04)

***
Fischer
et al
(2011)

Beta

Probability
of unused
prescriptions

0.29

Claxton et
al (2001)

(0.232 –
0.348)

***

Beta

Probability
of unfilled
prescriptions

0.033

-

(0.026 0.04)

***

Beta

Average
number of
prescriptions
written per
visit

3

NAMCS
/NHAMCS

(2.4 – 3.6)

***

-

Total number
of visits
involving
written
prescriptions

277,226,561 MEPS

***

-

(221,781,249
332,671,873)
**

*(Average cost of office based and other outpatient visits for new patient + average cost of office
based and other outpatient visits for established patient) divided by 2: (106.1 + 71.81)/2 =
45

88.955; however, $29.7 was used in the model based on the assumption that three
prescriptions are written per visit
**Rounded to the nearest whole number
*** ±20% was used due to lack of data
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Chapter 4

Results

Base case analysis
An estimated 831,679,683 prescriptions were written in outpatient settings in 2012. The
total number of unfilled, abandoned, and unused prescriptions is summarized in Table
4.1. Data were analyzed by decision analysis modeling and the base case results are
shown in Figure 4.1. The weighted average cost per wasted prescription (either unfilled,
abandoned, or unused prescription) is $37; mean cost per unfilled, abandoned, and
unused prescription is $30, $44, and $126, respectively. The total annual direct medical
costs associated with wastage in delivery of care attributed to medication waste is
estimated at $30.4 billion. Table 4.2 shows a breakdown of overall cost by waste
component; unused prescription medications contribute to more than 93% of the overall
cost.
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Table 4.1. Total number of unfilled, abandoned, and unused prescriptions
Method of calculation

Total number of
prescriptions

Unfilled
prescriptions

0.033* X total no. of written
prescriptions (831,679,683***)

27,445430

Abandoned
prescriptions

0.033* X total no. of filled
prescriptions (804,234,253****)

26,539,730

Unused
prescriptions

0.29** X total no. of picked up
prescriptions (777,694,523*****)

225,531,412

*Shrank et al (2010)
** Claxton et al (2001)
***Total number of physician visits (MEPS 2012) times 3 prescriptions per visit
****Total number of written prescriptions times rate of filled prescriptions (0.967)
*****Total number of filled prescriptions – total number of abandoned prescriptions

Figure 4.1 Base case results using decision analysis modeling. The arrow indicates the
weighted average cost per a wasted prescription.
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Table 4.2. Overall cost by unfilled, abandoned and unused prescriptions*
Cost component

No. of occurrences in
one year**

Mean cost
per event

Annual direct
medical costs
(in millions)**

Unfilled prescriptions

27,445,430

$30

$823

Abandoned
prescriptions
Unused prescriptions

26,539,730

$44

$1,168

225,531,412

$126

$28,417.0

Total annual direct
medical costs
*All

$30,408

costs are in US dollars 2014 values
to the nearest whole number

**Rounded

Table 4.3 Total direct medical costs by type of visit
Office based
visits

Hospital
outpatient visits

Emergency
room visits

Number of visits involving
written prescriptions

244,286,605

12,433,294

20,506,662

Number of prescriptions*

732,859,815

37,299,882

61,519,986

Annual direct medical
costs**
(in millions)

$27,116

$1,380

$2,276

Share of the total cost***

89.2%

4.5%

7.5%

*No. of prescriptions = No. of visits involving written prescriptions X 3
**Rounded to the nearest whole number
***Numbers may not add to 100 due to rounding
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11%
28%
Dispensing cost
Ingredient cost

Physician's visit cost

61%

Figure 4.2 Share of dispensing cost and ingredient cost to overall cost

The total estimated cost is also presented in terms of type of outpatient visit. The
share of office based visits, hospital outpatient visits, and emergency room visits to
overall cost is shown in Table 4.3. Prescriptions written in physician’s office account for
most of the waste with an estimated cost of $27 billion.
The share of dispensing cost and ingredient cost was also calculated. The total
average dispensing cost incurred by abandoned prescriptions and unused prescription
medications was estimated at $3.5 billion, which represents 11.5% of the overall cost.
The estimated average ingredient cost per prescription estimated was $82 and the total
average ingredient cost was $18.5 billion, which represents almost 61% of the total
estimated cost. Figure 4.2 shows the share of dispensing cost, ingredient cost,
physician’s visit cost to overall cost.
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Sensitivity analyses
One way sensitivity analysis
A Tornado diagram illustrated one way sensitivity analyses for all variables in the model
(Figure 4.3). Overall cost was most sensitive to the average rate of unused prescription
medications, costs per office based visits, and cost of the medications prescribed.
Varying the probability of unused medications over ±20% range resulted in
approximately ± $5.4 billion effect on overall estimated cost. When the mean office
based visit cost varied between ($0 and $30), the total cost ranged from $21.6 billion to
$30.8 billion. Mean prescription costs had an effect of ± $1.3 billion on the overall
estimated cost. Mean dispensing costs, probability of medications being abandoned,
and probability of prescriptions not being filled had little effect on overall costs of
medication waste (Table 4.4).
Probabilistic sensitivity analysis (Monte Carlo simulation)
A probabilistic sensitivity analysis (PSA) was conducted using all the variables in the
model. A Monte Carlo simulation was run for 10 thousand iterations giving an average
expected cost per wasted prescription of $37 (95%CI: $27 – $47) and thus, an overall
cost of $30.4 billion (95% CI: $22.5 billion – $39.1 billion). Results of Monte Carlo
simulation are summarized in Table 4.5.
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Figure 4.4 One way sensitivity analysis on all variables: box represent range of values
used in sensitivity analysis for each variable.
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Table 4.4 Results of one way sensitivity analyses (USD 2014 values)*
Variable

Range

Average cost
per wasted
prescription

Total annual
direct medical
costs**
(in millions)

Mean office based
physician’s visit and
other outpatient visits
cost

($0 - $30)

($26 - $37)

($21,624 –
$30,772)

Mean dispensing cost

($11 – $17)

($36 – $37)

($29,940 –
$30,772)

Mean prescription cost

($90– $102)

($35 - $38)

($29,109 –
$31,604)

Probability of
abandoned
prescriptions

(0.026 - 0.04)

($37***)

($30,772)

Probability of unused
prescriptions

(0.232 – 0.348)

($30 – 443)

($24,950 –
$35,762)

Probability of unfilled
prescriptions

(0.026 - 0.04)

($37***)

($30,772)

Average no. of
prescriptions written per
visit

(2.4 – 3.6)

-

($24,618 –
$36,927)

Number of visits
involving written
prescriptions**

(221,781,249 332,671,873)

-

($24,618 –
$36,927)

*USD: US dollars
** Rounded to the nearest whole number
***Varying the probability over the range (0.026 – 0.04) yields an average cost of
wasted prescription of $37
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Table 4.5 Results of probabilistic sensitivity analysis (USD 2014 values)*
After 10,000 simulations Expected cost per wasted prescription

Mean

$37

Median

$36

SD

$5

Minimum

$22

Maximum

$58

*USD: US dollars.
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Chapter 5

Section 5.1: Discussion

This study examines medication waste associated with the medication use process.
It quantifies the costs of medication waste in the United States exclusive of impact on
health outcomes. It is unique in its exploration of the waste associated with wasted
health care inputs including physician time spent diagnosing and prescribing for
medications the patient does not use or uses inappropriately, time spent by pharmacists
who fill prescriptions that are not picked up or taken incorrectly, and costs of
medications which are dispensed but not taken as directed.
In this research, a model was developed which used a unique definition of
medication waste. Other studies defined waste related to impact on health outcomes or
environmental effects. This study defined medication waste in terms of waste in
prescribing, dispensing, and non-consumption of medications. Therefore costs
estimated in the study were specific to waste in delivery of care due to unfilled,
abandoned, and unused prescription medications. Wastage in delivery of care means
that healthcare personnel squander their time and efforts in activities that don’t result in
any meaningful benefit to patients. In this study, the total estimated costs associated
with such waste was $30.4 billion (95% CI: $22.5 billion – $39.1 billion). This sum
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excludes costs related to hospitalizations, physician visits, nursing home admissions,
emergency department visits, and any additional resources used because of medication
waste.
Unused prescription medications contributed most to the overall cost of medication
waste. Figure 5.1 illustrates the relative impact of each component on overall
medication waste. Unused prescription medications accounted for most of the waste
with a total cost of more than $28 billion. Improving medication adherence in patients
can reduce this waste significantly.

3%

4%
Unfilled prescriptions
Abandoned prescriptions
Unused prescriptions

93%

Figure 5.1 Relative impact of each component on overall medication waste

Compared to other studies that examined unused medications, this study used a
novel approach. Other studies only included the ingredient cost of medications and use
the Average Wholesale Price (AWP) to estimate the cost of unused
medications.95,100,101,102 In contrast, we incorporated costs of dispensing and physician’s
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visits as components of the overall cost of unused prescription medications. This
captured waste in the medication use system that was ignored in previous research.
In addition, the data used for estimating the cost of wasted prescriptions was
collected from nationally representative sources, something which most other
encountered studies failed to do. Only two other studies attempted to quantify costs
nationally. One used a single community pharmacy to extrapolate their findings
nationwide.103 The other used a convenience sample of 73 New Hampshire retirement
community residents to come up with an estimate of medication waste in senior
populations.95 The causes behind medication waste are complex and varied. Individual
characteristics of patients like physical impairments, cognitive problems, and agerelated concerns may prevent them from filling, picking up, or taking prescription
medications as directed. The patient's medical condition (e.g., depression) may also get
in the way. Structural barriers in the US Health Care System like inadequate continuity
of care or poor provider–patient communications can prevent appropriate medication
use. In addition, the complexity of therapeutic regimens, adverse effects associated with
medication, and socioeconomic causes can reduce effective medication use.
Because of the complexity of causes behind medication waste, the solution will
require diverse strategies that increase patient engagement and participation in their
care. Reducing medication waste requires patients to fill, pick up, and take their
medications. Health care providers like physicians and pharmacists can make the
process easier, but patients must do their job too.
Improving relationships between patients and their providers, both physicians and
pharmacists combined with systems that address the barriers to appropriate patient
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behaviors can help reduce prescription drug waste. Innovations like appointment based
medication synchronization can reduce medication waste.
Appointment based medication synchronization (ABMS) can reduce waste by
allowing patients to meet with their pharmacists to solve medication-related problems
and synchronize prescriptions to be dispensed on a single day of the month.112
Significant improvement in medication adherence has been demonstrated with ABMS.
Better adherence with ABMS may also be associated with less waste.
ABMS blends technology with face-to-face contact with pharmacists to address the
causes of non-adherence and medication waste. It allows pharmacists to proactively
manage patients' medication-related needs. ABMS provides the pharmacist an
opportunity to engage in mutual problem solving with the patient about their medications
and it can help resolve issues like simple forgetfulness, poor continuity of care, poor
provider–patient communications, and insurance glitches.
Our definition of medication waste is unique. A study of medication waste conducted
by the IMS institute published in 2013 estimated that $213 billion are wasted due to
suboptimal use of medications.6 Waste was defined in terms of six areas listed in Table
5.1. Medication non-adherence (primary and secondary) accounted for 50% of the total
waste. For each area, costs were calculated based on increased utilization of four sites
of care: hospitalizations, outpatient visits, pharmacy, and emergency room visits, which
occurred as consequences of the suboptimal use of medications. Pharmacy utilization
accounted for $22 billion (10%) of the total estimated cost; this is because more
prescriptions are issued to patients with deteriorated health conditions as a result of
medication non-adherence.
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Our study differs from the IMS study in the definition of medication waste and the
related costs. Table 5.2 compared the different components considered by both studies.
This study has a number of limitations. The first was related to the specific types of
costs we captured. We only looked at direct medical costs associated with wastage in
delivery of care. There are other direct medical and non-medical costs as well as
indirect costs that are related to the problem. These unaddressed costs include cost of
impact on health outcomes, which may result from worsening health conditions; cost of
impact on environment as a consequence of water and soil pollution; and cost of
implementing strategies to overcome the problem such as medication take back events.
Thus, our estimate of $30.4 billion represents only a small portion of the economic
burden of medication waste, which may be addressed in future research.
Another limitation is that we were not able to determine what percentage of all
dispensed medications are not used. We only captured the percentage of unused
medications due to secondary non-adherence. This is because we obtained the rate of
unused medications from a previous study that evaluated medication non-adherence.
There is an undetermined percentage of unused medications caused by other factors
such as treatment resistance, overprescribing, patients’ death, and others.
Another limitation is the variability in our sources. Our data came from many
sources -- some published and other from secondary databases. The challenge was to
link the data from different resources and make them compatible. Also, some
assumptions were made about variables because data was not available. We attempted
to address issues of variability and compatibility in the sensitivity analyses.

59

When conducting the study, our intention was to focus on patient’s role in leading to
medication waste, more specifically, patients’ actions or non-actions in the medication
use process. However, this was not necessarily met when we looked at unfilled and
abandoned prescriptions. Patient’s intention to not fill or abandon a prescription could
not be captured through the literature. In other words, such actions could happen as a
consequence of other factors rather than patient’s intention to not use the prescribed
medicine. These factors include the availability of medicine at home, physician’s
instructions to not fill the prescription until the symptoms last for a number of days, or it
could be the payer who refuses the prescription.
Also, it is possible that we overestimated the overall cost because we used
physician’s visit costs as one of the costs associated with unfilled, abandoned, and
unused prescriptions. However, there is still an economic value in the physician’s visit
beyond writing a prescription. When physician’s visit cost was eliminated from the
model in the sensitivity analysis, the overall estimated cost dropped by almost $9 billion,
which constitutes approximately one third of the overall estimated cost.
Finally, there is limited generalizability of our results. We used data based on
community pharmacies only and thus, it may not be applicable to other outpatient
pharmacies.
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Table 5.1 Areas of suboptimal use of medications and associated costs based on IMS
study6
Area

Cost
(In billion)

Medication non-adherence

$105.4

Delayed evidence based treatment practice $39.5
Antibiotic misuse

$35.1

Medication errors

$20.0

Suboptimal generics use

$11.9

Mismanaged polypharmacy in the elderly

$1.3

Total cost

$213.2

Table 5.2 Comparison between the current study and the IMS study
Type of waste

Associated
cost
(in billion)

Total estimated
cost
(in billion)

Current
study

Unfilled prescriptions
Abandoned prescriptions
Unused prescription
medications

$0.8
$1.2
$28.4

$30.4

IMS study6

Hospital admissions
Outpatient visits
Prescriptions
Emergency room visits

$140
$45
$22
$6
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$213

Section 5.2: Conclusion

Medication waste associated with unfilled, abandoned, and unused prescription
medications is a significant burden on the US Healthcare System. Medication use
process starts when a physician writes a medication prescription and ends by patients
using or not using their dispensed medications. Patients who don’t fulfill their role in the
medication use process cause a considerable amount of monetary wastage estimated
in our study at $30.4 billion. Instead of being wasted, money spent on these avoidable
costs could be used to treat a large number of patients.
There are different reasons that lead to medication waste; patients’ medication nonadherence is the primary leader to such a problem. To reduce the intensity of
medication waste, healthcare policy makers should focus on stablishing plans that help
increase patient engagement in their care.
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Section 5.3: Study implications

This study estimated the overall cost of medication waste considering only wastage
inputs. Future studies that address medication waste considering other direct and
indirect costs are needed to provide a more comprehensive estimate of the overall cost.
Our study is limited to waste in the United States healthcare system. Efforts should
be increased to reduce waste in the US and worldwide.
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